Cargando…
A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia
OBJECTIVE: To determine the efficacy of acotiamide, an acetylcholinesterase inhibitor, in patients with functional dyspepsia (FD) in a 4-week trial METHODS: A multicentre, randomised, placebo-controlled, parallel-group, phase III trial was carried out, in which patients with FD received 100 mg of ac...
Autores principales: | Matsueda, Kei, Hongo, Michio, Tack, Jan, Saito, Youichi, Kato, Hiroki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3345932/ https://www.ncbi.nlm.nih.gov/pubmed/22157329 http://dx.doi.org/10.1136/gutjnl-2011-301454 |
Ejemplares similares
-
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia
por: Wauters, Lucas, et al.
Publicado: (2021) -
Do prokinetic agents provide symptom relief through acceleration of gastric emptying? An update and revision of the existing evidence
por: Goelen, Nick, et al.
Publicado: (2023) -
Worldwide prevalence and burden of gastroparesis‐like symptoms as defined by the United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis
por: Huang, I‐Hsuan, et al.
Publicado: (2022) -
A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D)
por: Lam, Ching, et al.
Publicado: (2016) -
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis
por: Schol, Jolien, et al.
Publicado: (2021)